Amoeba-like diversification built on strategic R&D (1980)

How do you hold stability and progress at the same time?

Underneath this decision is a refusal to let the safety of being the oligopoly leader become a reason to stop growing. Asahi Glass held about half the domestic flat-glass market and owned a business in which whatever it made, it sold. Rather than settle into that comfort, it turned research and development toward creating businesses over the long term, adding adjacent lines one at a time, each connected to the core technology. Increasing research headcount alone in the middle of a cost-cutting programme says a good deal about a management that put the accumulation of technology ahead of immediate earnings.

The word amoeba-like carried a deliberate looseness about which direction diversification should take. Vertical moves back into raw materials, horizontal moves into new applications, and the spinning-off of technologies that did not fit into separate companies — all of them ran back to the core glass technology. This pattern later produced display glass and fluorine products, and in the 2010s stretched as far as a portfolio shift that included life sciences. To the question of how to hold stability and progress at the same time, Asahi Glass answered by continuing to add businesses around a technological core.